NCT06104774

Brief Summary

To explore the effect of a family-centered, eight-week, progressive sit-to-stand Tai Chi exercise on lung function and mental health in patients after thoracoscopic surgery\_

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

October 20, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 27, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 24, 2025

Status Verified

April 1, 2025

Enrollment Period

2.2 years

First QC Date

October 18, 2023

Last Update Submit

April 20, 2025

Conditions

Keywords

Tai Chi exerciseLung cancerthoracoscopic surgeryLung functionMental HealthSleepFamily-Centered

Outcome Measures

Primary Outcomes (3)

  • vital capacity (VC)

    data will be collected through lung function test

    admission day, discharge 1 day, 7 day after discharge, one month after discharge, two months after discharge

  • forced vital capacity (FVC)

    data will be collected through lung function test

    admission day, discharge 1 day, 7 day after discharge, one month after discharge, two months after discharge

  • forced expiratory volume in one second (FEV1)

    data will be collected through lung function test

    admission day, discharge 1 day, 7 day after discharge, one month after discharge, two months after discharge

Secondary Outcomes (1)

  • Hospital anxiety and depression scale composite

    Baseline (Before operation), immediately post-operation, discharged 1 day, one week after discharge, one month after discharge, two months after discharge

Study Arms (2)

Tai Chi group

EXPERIMENTAL

After recruitment, participants will receive Tai Chi Exercise teaching. In the acupressure group, participants will receive acupressure treatment.

Behavioral: Tai Chi Exercise

Control group

NO INTERVENTION

conventional treatment

Interventions

The experimental group will receive Tai Chi exercise and routine treatment after the operation, and after discharge from the hospital, they will perform Tai Chi exercise three times a week, 50 minutes each time, for a total of eight weeks after discharge.

Tai Chi group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalized to receive thoracoscopic lobectomy, wedge/partial resection, lobectomy, or sleeve resection.
  • American Society of Anesthesiologists (ASA) physiological status classification I-II (ASA, 2019).ASA Physical Status Class I: A healthy person who is healthy and does not smoke or drink.ASA physical status class II: People with mild chronic diseases but no substantial functional limitations.
  • Those who can walk on their own without any impairment in limb movement.
  • Able to communicate in Chinese or Taiwanese.

You may not qualify if:

  • Individuals requiring chemotherapy and radiation therapy for malignant tumors.
  • Those who have practiced Tai Chi, Qigong, external elixir exercises, or pulmonary exercises within the past year.
  • Anticipating hospitalization or surgical treatment within the next three months.
  • Individuals with musculoskeletal or peripheral vascular diseases.
  • Individuals with visual impairment, intellectual disabilities, or memory loss.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University

Taichung, North Dist., 404327, Taiwan

RECRUITING

MeSH Terms

Conditions

Thoracic NeoplasmsLung NeoplasmsPsychological Well-Being

Interventions

Aquatic Therapy

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsRespiratory Tract NeoplasmsLung DiseasesRespiratory Tract DiseasesPersonal SatisfactionBehavior

Intervention Hierarchy (Ancestors)

HydrotherapyPhysical Therapy ModalitiesTherapeuticsRehabilitation

Study Officials

  • Hsing-Chi Hsu, Ph.D

    HungKuang University, Taiwan

    PRINCIPAL INVESTIGATOR
  • Kai-yu Tseng, Ph.D

    Central Taiwan University of Science and Technology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hsin-Yuan Fang, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice Superintendent

Study Record Dates

First Submitted

October 18, 2023

First Posted

October 27, 2023

Study Start

October 20, 2023

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

April 24, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations